by Columbia University Irving Medical Center Credit: Cell Metabolism (2023). DOI: 10.1016/j.cmet.2023.06.014 Warfarin, a widely used blood thinner, appears to have potent anti-cancer properties, according to a study by Columbia University researchers. The study, conducted in human cells and in mice, found that warfarin stops tumors from interfering with a self-destruct mechanism that cells initiate when they detect mutations...